71 related articles for article (PubMed ID: 8108596)
1. [Heparin and lipoprotein(a). Observations during hemodialysis].
Salvini P; Maddaloni E; Levi della Vida MV; Parma A; Corpetti MG; Di Lorenzo M
Recenti Prog Med; 1993 Dec; 84(12):828-33. PubMed ID: 8108596
[TBL] [Abstract][Full Text] [Related]
2. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
[TBL] [Abstract][Full Text] [Related]
3. Effects of heparin and dalteparin on oxidative stress during hemodialysis in patients with end-stage renal disease.
Nassiri AA; Hakemi MS; Soulati M; Marashian M; Rahbar K; Azizi F
Iran J Kidney Dis; 2009 Jul; 3(3):162-7. PubMed ID: 19617666
[TBL] [Abstract][Full Text] [Related]
4. [When lipids increase in dialysis: the role of heparin! Standard heparin increases, low-molecular-weight heparin lowers triglycerides].
Wiemer J; Scherberich JE
MMW Fortschr Med; 1999 Oct; 141(43):29-32. PubMed ID: 10912118
[TBL] [Abstract][Full Text] [Related]
5. Post-dialysis retention of blood lipoproteins and apolipoproteins in patients with end-stage renal disease on maintenance haemodialysis in Kuwait.
Al-Rashidi M; Hussain AA; Nampoory MR; Al-Ali JH; Akanji AO
Clin Chim Acta; 2004 Jun; 344(1-2):149-54. PubMed ID: 15149883
[TBL] [Abstract][Full Text] [Related]
6. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
Kronenberg F; König P; Lhotta K; Steinmetz A; Dieplinger H
Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
[TBL] [Abstract][Full Text] [Related]
7. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
Takegoshi T; Kitoh C; Yamazaki Y
Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
[TBL] [Abstract][Full Text] [Related]
8. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
Zwolińska D; Szprynger K
Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
[TBL] [Abstract][Full Text] [Related]
9. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients.
Joy MS; Dornbrook-Lavender KA; Chin H; Hogan SL; Denu-Ciocca C
Ann Pharmacother; 2008 Jan; 42(1):9-15. PubMed ID: 18000162
[TBL] [Abstract][Full Text] [Related]
10. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
11. Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major.
Al-Quobaili FA; Abou Asali IE
Saudi Med J; 2004 Jul; 25(7):871-5. PubMed ID: 15235691
[TBL] [Abstract][Full Text] [Related]
12. Oxidized low-density lipoprotein biomarkers in patients with end-stage renal failure: acute effects of hemodialysis.
Bossola M; Tazza L; Merki E; Giungi S; Luciani G; Miller ER; Lin EB; Tortorelli A; Tsimikas S
Blood Purif; 2007; 25(5-6):457-65. PubMed ID: 18075247
[TBL] [Abstract][Full Text] [Related]
13. [Influence of hemodialysis, heparin and protamin on the pre-beta fraction of lipoproteins in patients with chronic kidney failure].
Koslík S; Takác M; Koslíkova G
Z Gesamte Inn Med; 1977 Dec; 32(23):658-61. PubMed ID: 204117
[TBL] [Abstract][Full Text] [Related]
14. Acute effect of heparin on lipid parameters in patients on renal replacement therapy.
Katopodis KP; Koliousi E; Gouva C; Balafa O; Bairaktari E; Ikonomou M; Elisaf MS; Siamopoulos KC
ASAIO J; 2007; 53(1):46-9. PubMed ID: 17237649
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein alterations in hemodialysis: differences between diabetic and nondiabetic patients.
González AI; Schreier L; Elbert A; Berg G; Beresan H; López G; Wikinski R
Metabolism; 2003 Jan; 52(1):116-21. PubMed ID: 12524671
[TBL] [Abstract][Full Text] [Related]
16. Lipoprotein (a) in patients on hemodialysis.
Díaz-Peromingo JA; Carbajal DG; Albán-Salgado A
Acta Med Austriaca; 2004 Aug; 31(3):73-5. PubMed ID: 15515480
[TBL] [Abstract][Full Text] [Related]
17. Low density lipoprotein cholesterol, lipoprotein(a), and apo(a) isoforms in the elderly: relationship to fasting insulin. Associazione Medica Sabin.
Carantoni M; Zuliani G; Bader G; Palmieri E; Volpato S; Passaro A; Imbastaro T; Mezzetti A; Fellin R
Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):228-33. PubMed ID: 10656169
[TBL] [Abstract][Full Text] [Related]
18. Impact of abdominal visceral fat, growth hormone, fitness, and insulin on lipids and lipoproteins in older adults.
Weltman A; Despres JP; Clasey JL; Weltman JY; Wideman L; Kanaley J; Patrie J; Bergeron J; Thorner MO; Bouchard C; Hartman ML
Metabolism; 2003 Jan; 52(1):73-80. PubMed ID: 12524665
[TBL] [Abstract][Full Text] [Related]
19. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
20. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
Misra M; Webb AT; Reaveley DA; Doherty E; O'Donnell M; Seed M; Brown EA
Adv Perit Dial; 1997; 13():168-73. PubMed ID: 9360675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
